Home
Prolong Pharmaceuticals

Prolong Pharmaceuticals Market Share Analysis for November 2025

we are a clinical-stage biopharma leader developing innovative treatments for cns, hematology, and respiratory disorders.

Health > Biotechnology and Pharmaceuticals

Domainprolongpharma.com

Year Founded2005

Employees51 - 200

Annual Revenue$25M - $50M

Prolong Pharmaceuticals

Prolong Pharmaceuticals (including company regionals)

prolongpharma.com

See more website traffic and engagement information

Prolong Pharmaceuticals Revenue up to November 2025 is 25M - 50M

revenue generated by Prolong Pharmaceuticals top domains

Prolong Pharmaceuticals top domains revenue over 3 years

Revenue for Prolong Pharmaceuticals top domains

prolongpharma.com25M - 50M

See more with Sales Intelligence

Total visits to Prolong Pharmaceuticals's top domains

Understand Prolong Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

prolongpharma.com478

See more with Sales Intelligence

Avg. visit duration in Prolong Pharmaceuticals's top domains

Analyze Prolong Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

prolongpharma.com00:01:33

See more with Sales Intelligence

Avg. pageviews on Prolong Pharmaceuticals's top domains

See how Prolong Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

prolongpharma.com2.63

See more with Sales Intelligence

Prolong Pharmaceuticals top competitors by domain

Top similar sites in November 2025, ranked by their affinity

sklifescienceinc.comCompany NameSK Life Science IncEmployees51 - 200HQUnited States, New Jersey, paramusAnnual revenue$10M - $15MTotal visits5.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Prolong Pharmaceuticals

These are the website technologies, by industry, used by Prolong Pharmaceuticals top domains

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

More Technologies

4

See all

News & Signals from Prolong Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsProlongpharma attends event 2025 International Stroke Conference.Prolong Pharmaceuticals to present preliminary Phase 1 data from HEMERA-1 for PP-007 in Acute ischemic Stroke (AIS) at the 2025 International Stroke Conference (ISC).

NewsProlongpharma attended event ISC 2023 on Feb 9th '23.SOUTH PLAINFIELD, N.J. - (BUSINESS WIRE) - Prolong Pharmaceuticals, a clinical stage biopharmaceutical company, today announced that preliminary data from the recently completed Phase 1 clinical study of PP-007 (HEMERA-1) in acute ischemic stroke (AIS) patients will be presented in the Late-Breaking Science session during ISC 2023 in Dallas, TX and in the forthcoming PAIRS conference in Dubai.